Abstract: Nowadays, due to the increase in the number of aging population groups, there is also a growth of aging diseases such as Alzheimer's disease (AD), which is a progressive brain disorder that eventually results in death. At the moment, it cannot be cured, only its symptoms can be alleviated both by using pharmacological and non-pharmacological approaches in order to maintain and in some cases even enhance quality of life of people living with AD, as well as their caregivers. One of such non-pharmacological approaches is the use of assistive technology (AT), which can contribute to the improvement and maintenance of the quality of life of both patients and their caregivers. The purpose of this study was to explore what types of AT are mostly used by patients with AD and how these devices can help their caregivers. This was done by conducting a literature review of available sources found in the Web of Science, Scopus, and PubMed. The findings, apart from one study, reveal that AT may have the potential to maintain the quality of life of people with AD, especially in the early stages of the disease, as well as to mitigate the mental and physical burden of their caregivers. The most common types of AT for patients with AD are devices of daily living and safety devices. The less frequent are still telecare devices and devices to support engagement, social participation, and leisure. Future research should focus on the effectiveness of AT on the improvement of patients' symptoms, as well as on the development and use of AT for social interactions, which can be used in patients with AD of different degree of severity and have a positive impact on their behavioral and psychological symptoms.
Introduction
Currently, there are about 44 million people in the world living with Alzheimer's disease (AD). Due to the demographic trends toward the aging of population, this number will be rising. In fact, by 2050, this number will triple. 1 AD is a progressive neurological disorder, which first affects cognitive skills and eventually results in the inability to do the tasks of daily life. It is one of the most common forms of dementia. In the course of AD, many neurons stop functioning, lose connections with other neurons, and die. 2 AD damages neurons and their connections in parts of the brain involved in memory. It later affects areas in the cerebral cortex responsible for language, reasoning, and social behavior such apathy, depression, delusions, hallucinations, aggression, irrelevant sexual behavior, or sleeping problems. 3 The symptoms of AD gradually worsen and the patients will not be able to take care of themselves alone. Therefore, they begin to be severely dependent of someone's help, which is usually provided by a family member. For example, in 2016 there were 15.9 million family caregivers who It can be divided according to its purpose into supportive technologies, which help people to complete tasks; responsive technologies, which can help to control stress and raise alarms; and preventive technologies, which can help to prevent harm and raise alarms. 11 The AT can be a very simple device, such as a walking stick, a walking frame, or calendar clocks. It can be a more sophisticated device such as automatic lighting and telecare, such as movement, flood, gas, smoke, or fall detectors that automatically send a signal via a base unit connected to a telephone line to a caregiver, community alarm, or monitoring service, and which can call for assistance when it is needed. 11 Alzheimer's Society 11 distinguishes the following four types of AT on the basis of their purpose:
• Devices of daily living.
• Safety devices.
• Telecare devices.
• Devices to support engagement, social participation, and leisure.
Devices of daily living
These technologies include the devices, which help people with AD with their memory, orientation, and communication difficulties. These are mainly prospective memory aids including devices focused on time orientation, keeping appointments, or reminding people of attending social activities. 12 Furthermore, calendar clocks help them to be aware of the relevant date and time, while the orientation devices such as the locaters help them to find the way or things. The adapted telephones, on the contrary, help them with communication.
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Safety devices
Safety devices can enable people to live independently, as well as reduce worries of their loved ones about them. These technologies comprise different devices such as automatic lights, automated shut-off devices that can stop the gas supply if the gas has been left on, water isolation devices that control water taps and prevents flooding, or fall sensors that can register if a person has fallen. Therefore, AT is sometimes referred to as ambient assisted living (AAL) since its aim is also to support people to live independently. In addition, the AAL technologies can collect characteristics/data about patients with AD through a non-intrusive wireless sensor system, whose data can provide valuable information about these patients in real-time. 13 Moreover, these safety devices also include tracking devices or location-monitoring services, which enable to find the persons if they get lost and at the same time enable the persons with AD to call for help if they are disoriented and cannot find the way on their own. 14 
Telecare devices
Telecare usually refers to a system or devices that remotely monitor people living in their own home, enabling them to access support or response services when necessary. Various pieces of technology are connected via a telephone line or over the Internet. Telecare systems can include community alarms, sensors and movement detectors, video conferencing, or assistive robots. 15 Devices to support engagement, social participation, and leisure Apart from living independently and safe, it is important for people with AD to stay in touch with their family, friends, and peers since such a social contact has a positive impact on their cognition, mood, and well-being. 16 And with the boom of mobile technologies, it is quite easy. Patients can play 
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All these devices described above are targeted at the enhancement of the quality of life of people with AD, as well as their caregivers. However, each of the patients is individual and may have different needs. Therefore, it is important to carefully assess their needs and consequently, tailor this AT accordingly. 17 As Pino et al 18 claim, development of new assistive technologies to support patients with AD and their caregivers requires the enduser involvement throughout all the development lifecycle.
The purpose of this study was to explore what types of AT are mostly used by patients with AD and how these devices can help them and their caregivers. The authors thus set three main research questions, which are as follows: 1. What types of AT are used by patients with AD? 2. What are the main benefits of AT both for patients and their caregivers? 3. Do the findings of the detected studies evidence any AT effectiveness on the maintenance or even improvement of patients' symptoms, and thus their quality of life?
Methods
The authors conducted a literature review of available sources found in the Web of Science, Scopus, and PubMed. The methodology of this study was based on Moher et al. 19 The search keywords were as follows: assistive technology AND Alzheimer's disease, assistive technology AND dementia, devices of daily living AND Alzheimer's disease, safety devices AND Alzheimer's disease, telecare devices AND Alzheimer's disease, leisure devices AND Alzheimer's disease, social devices AND Alzheimer's disease, engagement devices AND Alzheimer's disease, devices of daily living AND dementia, safety devices AND dementia, telecare devices AND dementia, leisure devices AND dementia, social devices AND dementia, engagement devices AND dementia. The search was limited only by the end of the study, that is, July 2018.
From the database/journal/web page searches, 687 titles/ abstracts were retrieved. The title and abstract of some identified studies were checked for relevance. Subsequently, the search was performed again and focused on the occurrence of at least one keyword in the title or abstract, thus significantly narrowing the selection. It provided the authors with a relevant entry-level file base. Altogether 73 studies were found. After removing duplicates and titles/abstracts unrelated to the research topic, 37 peer-reviewed, studies written in English were identified. After the full-text analysis, 10 studies were eventually included in final analysis ( Figure 1 ).
A study was included if it was a randomized controlled study, an experimental study or a case study; it dealt with the research topic, ie, AT as an intervention tool for people with AD, and possibly their caregivers; was limited by the end of July 2018; and if it was written in English. Thus, descriptive or review studies on the research topic were excluded for the analysis. Furthermore, the studies focusing on dementia in general, 16, [20] [21] [22] exclusively only on caregivers, 23 or containing no intervention 24 were also excluded. In this way, this review differs from the review by Meiland et al 9 who did not set any limitations as far as the topic on the use of AT and patients with dementia is concerned. In their study, they analyzed mainly reviews. Nevertheless, remaining suitable studies were then used in other parts of this manuscript (ie, "Introduction" or "Discussion of the findings" section) in order to describe the topic and compare the findings.
Findings
Altogether ten studies [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] were detected. Nine of them were experimental studies, [26] [27] [28] [29] [30] [31] [32] [33] [34] and one study 24 was a randomized controlled trial. All patients suffered from AD, and this was measured with the Mini-Mental State Examination test. This test is used worldwide to detect cognitive function, dementia, and AD. The methodology for measuring the outcomes of the use of AT in patients with AD differed across the selected studies. The researchers used both quantitative 
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Klimova et al and qualitative methods, such as questionnaires, interviews, instrumental activities of daily living, recordings, and in some cases, statistical processing. The subject samples included between 1 and 48 patients with AD, including caregivers. These relatively small numbers of subjects are due to the inclusion of experimental/case studies whose samples are usually limited by the nature of the study. The intervention period ranged from 1 to 12 months. The AT included different devices, which were especially aimed at patients' safety and security 27, 28 and activities of daily living. 25, 26, 32, 33 We found only two studies focused on the devices to support leisure engagement 30 and cognitive training, 34 and one study 29 on telecare devices. The key limitation of the studies was the varying levels of AD among patients. The description of the analyzed studies and their findings are summarized in alphabetical order of their first author in Table 1 .
Discussion of the findings
Although there was only one RCT, 25 which revealed no improvement as far as behavioral symptoms, functional status, or QoL of hearing impaired AD patients and their caregivers after 6 months of hearing aid use are concerned, findings from other experimental studies indicate that AT may generate a positive effect on patients' and their caregivers' quality of life in several ways. In the early stages of AD, AT may especially promote their independent living, [26] [27] [28] [29] [31] [32] [33] which patients prefer 35, 36 and which can also delay the costly institutionalization. 37 In these early stages of AD, patients can also get engaged in leisure activities supported by AT, such as listening to music, picture viewing, or solving puzzles, which may have a positive effect not only on their mood but also on cognitive functions. 16, 30, 34 Furthermore, AT may help to maintain patients' safety and security, which thus means less stress and confidence not only for them but also less worries and greater relaxation for their caregivers. [27] [28] [29] In fact, nearly 45% of patients with AD suffer from depressive symptoms and 10%-45% from anxiety. 25, 38 As Franco et al 29 state, AT is able to detect loss of independence. It can, for instance, reveal the details of activity that people stop doing, for example, vacuuming or ironing. In addition, the use of robots, which can assist people with AD by providing them with stepwise prompts seems to be of more interest and motivation for people with mild-to-moderate AD. 33 At present, there are also animallike robots that engage patients with dementia and AD in social interactions and help them to reduce their behavioral and psychological symptoms. 38, 39 The results from the selected studies 27, 29, 32, 33 of this review confirm the findings of other studies 18, 37, 40 that it is desirable for the developers of AT to focus on the end-users, that is, the patients themselves, as well as on their caregivers, who should also be trained in their use. Moreover, the use of AT in the daily life of caregivers can help them to understand the disease process and manage situations in a way that is beneficial for both the parties. 35 The doctors should also be approached in order to judge the appropriateness of the device to patients' diagnosis and their needs. The developers should pay particular attention to the size of AT device, its weight, and visibility to reduce stigmatization, 21 as well as making it user-friendly to its users. 28 For instance, Czarnuch et al 41 developed a set of models that can predict the likelihood that patients with dementia, and AD, will require assistance during 20 activities of daily living without direct evaluation of their actual capabilities. These models are shaped by the following 13 factors: caregiver relation, age, marital status, place of residence, language, housing type, proximity to caregiver, use of professional service, informal primary caregiver, diagnosis of AD, diagnosis of dementia, time since diagnosis, and level of dependence on caregiver. Knowledge of task independence can then inform the development of AT for people with AD and improve their applicability and acceptance. Furthermore, there are also ethical concerns about the use of AT devices; some technologies may intrude patients' rights, privacy, and freedom such as a global positioning system used by patients with AD. Overall, there are two main ethical dilemmas: privacy and respect for autonomy vs safety and minimizing risks, and obtaining informed consent from persons with dementia due to their possible difficulties understanding the complexity of technology. 9 Therefore, patients with AD as well as their caregivers should be involved in the decision making and their consent should be sought. 42 In addition, Bennett et al 43 suggest establishing an approach that would evaluate innovative technologies with respect to human rights set in the United Nations Convention on the Rights of Persons with Disabilities.
The limitations of this review are a lack of available studies on the research topic, based on the inclusion and exclusion criteria set by the authors. Furthermore, the validity of the findings might also be influenced by varying levels of AD that were studied, different types of AT devices, short intervention periods, a lack of follow-up periods (in most of the studies), and a lack of other reliable data, for example, effect sizes. 
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Conclusion
Thus, based on the findings from this review, the research questions can be answered. The most common types of AT for patients with AD are devices of daily living and safety devices. The less frequent are still telecare devices and devices to support engagement, social participation, and leisure. The main benefits for patients using them include the feeling of being independent and the feeling of having confidence of being able to execute the activity of daily living, and thus, maintaining the quality of life, as well as reducing adverse behavioral and psychological symptoms. The caregivers then benefit from gaining more independence and mitigating their mental and physical burden. In fact, only two studies 26, 34 evidenced (through effect sizes) the effectiveness of AT on the improvement of patients' symptoms. Therefore, future research should focus on this issue, as well as on the development and use of AT for social interactions, which can be used in patients with AD of different degree of severity and have a positive impact on their behavioral and psychological symptoms.
